This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

20 May 2011

UK Invests in Personalised Medical Projects

The UK’s Technology Strategy Board and the Medical Research Council are jointly investing ?3.7m in seven major research projects for personalised medicine.

The UK's Medical Research Council and Technology Strategy Board will jointly invest £3.7m in seven major research projects, which will study and develop personalised medicine. The projects will be lead by pharmaceutical companies AstraZeneca UK, GlaxoSmithKline, Ig Innovations, Janssen UK and Randox Laboratories.


Four of the projects will develop the use of biomarkers to predict how groups of patients respond to inflammation and immunology therapies. In this way, therapies could be given only to relevant patient subgroups for better results in alleviating symptoms and side effects.


The other three projects relate to developing

Related News